崧盛股份(301002.SZ):崧盛投資擬協議轉讓5%的股份予京成紅聚6號基金
格隆匯11月4日丨崧盛股份(301002.SZ)公佈,近日,公司收到崧盛投資、北京京成九陽投資管理有限公司-京成紅聚6號證券私募投資基金(“京成紅聚6號基金”或“受讓方”)分別出具的簡式權益變動報吿書及其共同簽署的相關協議,獲悉崧盛投資於2022年11月4日與京成紅聚6號基金簽署了《股份轉讓協議》,崧盛投資擬通過協議轉讓方式向京成紅聚6號基金轉讓其持有的公司部分無限售流通股股份,轉讓股數614.4005萬股,佔公司總股本比例的5%;轉讓價格為16.856元/股,轉讓總價約1.04億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.